No Data
No Data
New Analyst Forecast: $MIST Given 'Hold' Rating
Milestone Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Milestone Pharmaceuticals Analyst Ratings
Express News | Milestone Pharmaceuticals Inc : H.c. Wainwright Cuts Target Price to $10 From $25
TD Cowen Downgrades Milestone Pharmaceuticals to Hold From Buy
TD Cowen Downgrades Milestone Pharmaceuticals(MIST.US) to Hold Rating